Bristol-Myers Squibb | BMY

Stock Price
64.82
Daily Change
-0.75%
Yearly
-13.68%
Q2 Forecast
63.76
Rating
Sell

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
AbbVie 138.35 0.71 0.52% -3.39%
Abbott 101.62 0.84 0.83% -7.31%
ALKERMES 31.37 -0.17 -0.54% 14.24%
Amgen 219.66 -1.10 -0.50% -8.48%
AstraZeneca 11,712.00 -38.00 -0.32% 18.89%
Biogen 308.88 3.98 1.31% 52.74%
Bristol-Myers Squibb 64.82 -0.49 -0.75% -13.68%
Coherus Biosciences 5.50 0.11 1.95% -18.23%
Catalent 38.62 -0.38 -0.97% -63.79%
Endo International 0.03 -0.03 -45.45% -91.22%
Gilead Sciences 78.19 -0.21 -0.27% 28.73%
GlaxoSmithKline 1,378.00 2.80 0.20% -20.65%
Horizon Pharma 99.53 0.11 0.11% 16.52%
Intercept Pharmaceuticals 12.01 -0.25 -2.00% -5.32%
J&J 160.05 -0.21 -0.13% -7.24%
Eli Lilly 447.68 2.02 0.45% 50.73%
Medtronic 83.65 0.55 0.66% -9.80%
Merck & Co 111.26 0.94 0.85% 27.62%
Novartis 90.17 -0.20 -0.22% 7.45%
Phibro Animal Health 13.52 -0.35 -2.49% -27.61%
Prestige Brands 58.12 -0.14 -0.23% 6.11%
Pfizer 38.97 -0.12 -0.31% -22.01%
Perrigo 33.37 -0.28 -0.83% -13.73%
Drreddys Laboratories 57.00 0.01 0.02% 3.37%
Regeneron Pharmaceuticals 747.36 -2.76 -0.37% 30.70%
Roche Holding 282.10 -1.85 -0.65% -10.14%
Revance Therapeutics 30.62 -0.52 -1.65% 154.91%
Sanofi 95.40 -0.04 -0.04% -1.52%
Sanofi 51.24 -0.30 -0.58% 0.65%
United Therapeutics 228.91 2.41 1.06% 3.74%
Zoetis 163.44 -0.86 -0.52% 1.21%

Indexes Price Day Year
US500 4303 9.42 0.22% 10.32%

Bristol-Myers Squibb

Bristol-Myers Squibb traded at $64.82 this Friday June 9th, decreasing $0.49 or 0.75 percent since the previous trading session. Looking back, over the last four weeks, Bristol-Myers Squibb lost 5.36 percent. Over the last 12 months, its price fell by 13.68 percent. Looking ahead, we forecast Bristol-Myers Squibb to be priced at 63.76 by the end of this quarter and at 58.37 in one year, according to Trading Economics global macro models projections and analysts expectations.

Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Its pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. Its products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics and government agencies.